Cerebroprotection by hypertension in ischemic stroke: The crumbling of a hypothesis

Circulation

Volumn 115, Issue 23, 2007, Pages 2907-2908

  Messerli, Franz H ^a,b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

Blood pressure; Cerebral infarction; Editorials; Hypertension; Stroke

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; DIHYDRALAZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; EPROSARTAN; NITRENDIPINE; PERINDOPRIL; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BRAIN INFARCTION SIZE; BRAIN PROTECTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; EDITORIAL; HEART INFARCTION; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; KIDNEY FAILURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMANS; HYPERTENSION;

EID: 34250328663     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.707976     Document Type: Editorial

References (20)

1. Scott RW. Clinical blood pressure. In: Tice F, ed. Practice of Medicine. Hagerstown, Md: WF Prior; 1946;6:93-114.
2. White PD. Heart Disease. 1st ed. New York, NY: McMillan Co; 1931.
3. Adams RD, Victor M. Principles of Neurology. 4th ed. New York, NY: McGraw Hill; 1989.
4. Britton M, de Faire U, Helmers C. Hazards of therapy for excessive hypertension in acute stroke. Acta Med Scand. 1980;207:253-257.
5. Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M, for the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007;115:2969-2975.
6. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet. 2001;358:1033-1041.
7. Gueyffier F, Boutitie F, Boissel JP, Coope J, Cutler J, Ekbom T, Fagard R, Friedman L, Perry HM, Pocock S, Prineas R, Schron E. INDANA: a meta-analysis on individual patient data in hypertension: protocol and preliminary results. Thérapie. 1995;50:353-362.
8. Elewa HF, Kozak A, Johnson MH, Ergul A, Fagan SC. Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection. J Hypertens. 2007;25:855-859.
9. Fagan SC, Kozak A, Hill WD, Pollock DM, Xu L, Johnson MH, Ergul A, Hess DC. Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. J Hypertens. 2006;24:535-539.
10. Fournier A, Messerli FH, Achard JM, Fernandez L. Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials. J Am Coll Cardiol. 2004;43:1343-1347.
11. Nishimura Y, Ito T, Saavedra JM. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke. 2000;31:2478 -2486.
12. Brdon J, Kaiser S, Hagemann F, Zhao Y, Culman J, Gohlke P. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke. J Hypertens. 2007;25:187-196.
13. Boutitie F, Oprisiub R, Achard JM, Mazouzc H, Wange J, Messerli FH, Fournier A. Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment and the potentially different effects on angiotensin II. J Hypertens. In press.
14. Schrader J, Luders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener HC, for the MOSES Study Group. Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES). Stroke. 2005;36:1218-1226.
15. Gohlke P, Von Kugelgen S, Jurgensen T, Kox T, Rascher W, Culman J, Unger T. Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats. J Hypertens. 2002;20:909-918.
16. Yatsu FM, Zivin J. Hypertension in acute ischemic stroke: not to treat. Arch Neurol. 1985;42:999 -1000.
17. Blood Pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev. 2001:CD000039.
18. COSSACS (Continue or Stop Post-Stroke Antihypertensives Collaborative Study): rationale and design. J Hypertens. 2005;23:455- 458.
19. Potter J, Robinson T, Ford G, James M, Jenkins D, Mistri A, Bulpitt C, Drummond A, Jagger C, Knight J, Markus H, Beevers G, Dewey M, Lees K, Moore A, Paul S, for the CHHIPS Trial Group. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) pilot trial: rationale and design. J Hypertens. 2005;23:649-655.
20. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276:1328-1331.